IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biomedical Engineering,Biomaterials,Bioengineering,Biotechnology
Reference73 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021
2. Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium;Pacheco-Pinedo;J. Clin. Invest.,2011
3. Evaluating the use of circulating MicroRNA profiles for lung cancer detection in symptomatic patients;Fehlmann;JAMA Oncol.,2020
4. Genomic landscape and immune microenvironment features of preinvasive and early invasive lung adenocarcinoma;Zhang;J. Thorac. Oncol.,2019
5. The role of m6A modification in the biological functions and diseases;Jiang;Signal Transduct. Targeted Ther.,2021
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. IGF2BP3-stabilized CAMK1 regulates the mitochondrial dynamics of renal tubule to alleviate diabetic nephropathy;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03
2. A review on the role of RNA methylation in aging-related diseases;International Journal of Biological Macromolecules;2024-01
3. IGF2BP2 attenuates intestinal epithelial cell ferroptosis in colitis by stabilizing m6A-modified GPX4 mRNA;Cytokine;2024-01
4. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases;Signal Transduction and Targeted Therapy;2023-12-10
5. Classical Monocyte Marker Gene Signatures (CMMGS) Identified by Analysis of Single-Cell and Bulk-RNA Sequencing to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma;2023-12-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3